India’s Defence Export Boom: Why Private Startups are the Real Play

India is witnessing a tectonic shift in its defence landscape, with export figures projected to significantly outpace government expectations. While traditional investors often flock to large public sector undertakings (PSUs), the real growth engine is emerging from agile private sector startups specializing in next-generation technology.

Surpassing Government Targets by 2030

The official government mandate aims for defence exports to reach ₹50,000 crore by FY32. However, market expert Sunil Subramaniam suggests this target is overly conservative. According to his projections, India’s defence exports are on track to hit between ₹60,000 crore and ₹65,000 crore by 2030. In fact, the momentum is so strong that the ₹50,000 crore milestone could be achieved as early as 2028.

This surge is driven by a fundamental change in modern warfare, where the global demand is shifting away from traditional frontline infantry toward unmanned systems.

The Pivot from PSUs to Private Tech Innovators

Most retail investors currently enter the sector through the Nifty Defence Index, which is heavily weighted toward public sector companies. While these PSUs dominate traditional arms and ammunition, Subramaniam warns that the real value is moving toward the private sector.

The "age of drones and UAVs" is being led by private innovators. These startups are focusing on:

  • Offensive and Defensive Drone Tech: Meeting the global demand for unmanned aerial vehicles (UAVs).
  • Battle-Tested Innovation: Utilizing domestic operational successes, such as Operation Sindoor, to prove capability.
  • Strategic Geographies: Tapping into the Gulf nations, which are rapidly building defence bases following recent regional tensions.

The Upcoming IPO Pipeline

For investors, the most significant opportunity may not lie in existing listed defence stocks, which currently face high valuations. Instead, the focus should shift to the upcoming IPO pipeline.

Because defence products have long gestation cycles, private players require significant equity capital to scale. Subramaniam expects a wave of defence-related private sector IPOs over the next 12 to 18 months. He suggests that as these new players enter the market, investors might rotate capital out of established PSU names, creating potential headwinds for current incumbents.

Beyond Defence: Pharma as a Strategic Dollar Play

While defence captures the headlines, the pharmaceutical sector is emerging as a superior "dollar play" compared to the IT sector. Despite recent rupee stability due to RBI interventions, medium-term currency depreciation is expected to benefit export-heavy pharma companies.

Key drivers in pharma include the return of Foreign Institutional Investor (FII) flows, the rise of the Contract Development and Manufacturing Organization (CDMO) segment, and specific opportunities in GLP-1 generics. While US tariff pressures remain a theoretical risk, the deep reliance of the US public healthcare system on Indian generics provides a significant safety net for the industry.

Key Takeaways

  • Exponential Growth: India's defence exports are expected to reach ₹65,000 crore by 2030, potentially hitting the government's ₹50,000 crore target four years early.
  • Private Sector Dominance: The real growth lies in private startups specializing in drones and UAVs, rather than traditional PSU-led ammunition manufacturing.
  • Investment Strategy: Investors should watch for a massive influx of defence-related IPOs over the next 18 months as private players seek capital to manage long product gestation cycles.